Tower Research Capital LLC (Trc) Acumen Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,624 shares of ABOS stock, worth $26,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,624
Previous 3,910
427.47%
Holding current value
$26,398
Previous $9,000
288.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ABOS
# of Institutions
81Shares Held
40.6MCall Options Held
28.6KPut Options Held
76.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$19.1 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.37 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$4.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.48 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $51.8M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...